Genetic landscape of sporadic vestibular schwannoma

被引:51
|
作者
Havik, Aril Loge [1 ,2 ,5 ]
Bruland, Ove [5 ]
Myrseth, Erling [6 ]
Miletic, Hrvoje [3 ,4 ,7 ]
Aarhus, Mads [8 ]
Knappskog, Per-Morten [2 ,5 ]
Lund-Johansen, Morten [1 ,4 ,6 ]
机构
[1] Univ Bergen, Dept Clin Med, Bergen, Norway
[2] Univ Bergen, Dept Clin Sci, Bergen, Norway
[3] Univ Bergen, Dept Biomed, Bergen, Norway
[4] Univ Bergen, KG Jebsen Brain Tumor Res Ctr, Bergen, Norway
[5] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway
[6] Haukeland Hosp, Dept Neurosurg, N-5009 Bergen, Norway
[7] Haukeland Hosp, Dept Pathol, Bergen, Norway
[8] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway
关键词
vestibular schwannoma; NF2; axonal guidance; next-generation sequencing; molecular biology; USP8; CDC27; COMPARATIVE GENOMIC HYBRIDIZATION; NEUROFIBROMATOSIS TYPE-2 GENE; MALIGNANT-TRANSFORMATION; MICROARRAY ANALYSIS; MERLIN; CANCER; PHOSPHORYLATION; SUPPRESSOR; EXPRESSION; MUTATIONS;
D O I
10.3171/2016.10.JNS161384
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Vestibular schwannoma (VS) is a benign tumor with associated morbidities and reduced quality of life. Except for mutations in NF2, the genetic landscape of VS remains to be elucidated. Little is known about the effect of Gamma Knife radiosurgery (GKRS) on the VS genome. The aim of this study was to characterize mutations occurring in this tumor to identify new genes and signaling pathways important for the development of VS. In addition, the authors sought to evaluate whether GKRS resulted in an increase in the number of mutations. METHODS Forty-six sporadic VSs, including 8 GKRS-treated tumors and corresponding blood samples, were subjected to whole-exome sequencing and tumor-specific DNA variants were called. Pathway analysis was performed using the Ingenuity Pathway Analysis software. In addition, multiplex ligation-dependent probe amplification was performed to characterize copy number variations in the NF2 gene, and microsatellite instability testing was done to investigate for DNA replication error. RESULTS With the exception of a single sample with an aggressive phenotype that harbored a large number of mutations, most samples showed a relatively low number of mutations. A median of 14 tumor-specific mutations in each sample were identified. The GKRS-treated tumors harbored no more mutations than the rest of the group. A clustering of mutations in the cancer-related axonal guidance pathway was identified (25 patients), as well as mutations in the CDC27 (5 patients) and USP8 (3 patients) genes. Thirty-five tumors harbored mutations in NF2 and 16 tumors had 2 mutational hits. The samples without detectable NF2 mutations harbored mutations in genes that could be linked to NF2 or to NF2-related functions. None of the tumors showed microsatellite instability. CONCLUSIONS The genetic landscape of VS seems to be quite heterogeneous; however, most samples had mutations in NF2 or in genes that could be linked to NF2. The results of this study do not link GKRS to an increased number of mutations.
引用
收藏
页码:911 / 922
页数:12
相关论文
共 50 条
  • [1] Deciphering the causal landscape: genetic insights into sporadic vestibular schwannoma risk factors through Mendelian Randomization
    Liu, Yuyang
    Feng, Hui
    Ma, Hengchao
    Li, Jing
    Yu, Yang
    Zhao, Hua
    Wang, Xiaoguang
    Li, Yun
    Zhang, Jun
    Liu, Qi
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [2] Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma
    Havik, Aril Loge
    Bruland, Ove
    Miletic, Hrvoje
    Poulsgaard, Lars
    Scheie, David
    Fugleholm, Kare
    Lund-Johansen, Morten
    Knappskog, Per-Morten
    ACTA NEUROCHIRURGICA, 2022, 164 (02) : 343 - 352
  • [3] Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma
    Aril Løge Håvik
    Ove Bruland
    Hrvoje Miletic
    Lars Poulsgaard
    David Scheie
    Kåre Fugleholm
    Morten Lund-Johansen
    Per-Morten Knappskog
    Acta Neurochirurgica, 2022, 164 : 343 - 352
  • [4] Management of Sporadic Vestibular Schwannoma
    Carlson, Matthew L.
    Link, Michael J.
    Wanna, George B.
    Driscoll, Colin L. W.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2015, 48 (03) : 407 - +
  • [5] Quality of Life in Sporadic Vestibular Schwannoma
    Marinelli, John P.
    Lohse, Christine M.
    Link, Michael J.
    Carlson, Matthew L.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2023, 56 (03) : 577 - 586
  • [6] Complications of Surgery for Sporadic Vestibular Schwannoma
    Mahboubi, Hossein
    Ahmed, Omar H.
    Yau, Amy Y.
    Ahmed, Yasmina C.
    Djalilian, Hamid R.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2014, 150 (02) : 275 - 281
  • [7] Vestibular Schwannoma Immune Landscape
    Abedalthagafi, Malak
    Bi, Linda
    Gupta, Saksham
    Dunn, Ian
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 692 - 692
  • [8] Proteomic Analysis of Vestibular Schwannoma: Conflicting Role of Apoptosis on the Pathophysiology of Sporadic Vestibular Schwannoma
    Seo, Jae-Hyun
    Park, Kyoung-Ho
    Jeon, Eun-Ju
    Chang, Ki-Hong
    Lee, Heejin
    Lee, Weonsun
    Park, Yong-Soo
    OTOLOGY & NEUROTOLOGY, 2015, 36 (04) : 714 - 719
  • [9] Sporadic vestibular schwannoma: a molecular testing summary
    Sadler, K. V.
    Bowers, N. L.
    Hartley, C.
    Smith, P. T.
    Tobi, S.
    Wallace, A. J.
    King, A. T.
    Lloyd, S. K. W.
    Rutherford, S. A.
    Pathmanaban, O. N.
    Hammerbeck-Ward, C.
    Freeman, S.
    Stapleton, E.
    Taylor, A.
    Shaw, A.
    Halliday, D.
    Smith, M. J.
    Evans, D. G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 551 - 551
  • [10] Double localization of a unilateral sporadic vestibular schwannoma
    Barbara, M.
    Ronchetti, F.
    Manni, V.
    Monini, S.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2008, 28 (01) : 34 - 37